Santori & Peters Inc’s Bristol-Myers Squibb BMY Stock Holding History

Santori & Peters Inc’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,964	Closed	-$213K	–	50
2022 Q4	$213K	Sell	2,964 -70	-2%	-$5.28K	0.13%	46
2022 Q3	$215K	Buy	3,034 +287	+10%	+$20.8K	0.14%	42
2022 Q2	$211K	Buy	+2,747	New	+$209K	0.14%	47
2022 Q1	–	Sell	-5,627	Closed	-$350K	–	56
2021 Q4	$350K	Buy	5,627 +36	+0.6%	+$2.11K	0.18%	39
2021 Q3	$330K	Buy	5,591 +31	+0.6%	+$2.04K	0.19%	40
2021 Q2	$371K	Buy	5,560 +32	+0.6%	+$2.09K	0.21%	39
2021 Q1	$348K	Sell	5,528 -7,130	-56%	-$444K	0.21%	41
2020 Q4	$791K	Buy	12,658 +63	+0.5%	+$3.87K	0.44%	26
2020 Q3	$759K	Buy	12,595 +7,195	+133%	+$433K	0.5%	26
2020 Q2	$317K	Sell	5,400 -6,922	-56%	-$414K	0.24%	41
2020 Q1	$686K	Buy	12,322 +29	+0.2%	+$1.77K	0.59%	20
2019 Q4	$789K	Buy	12,293 +2,776	+29%	+$159K	0.52%	27
2019 Q3	$482K	Buy	9,517 +124	+1%	+$5.83K	0.35%	36
2019 Q2	$426K	Buy	+9,393	New	+$438K	0.31%	42
2019 Q1	–	Sell	-9,326	Closed	-$484K	–	54
2018 Q4	$484K	Buy	+9,326	New	+$501K	0.43%	31
2018 Q1	–	Sell	-2,308	Closed	-$144K	–	116
2017 Q4	$144K	Buy	+2,308	New	+$144K	0.13%	59

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Santori & Peters Inc's BMY Position: Q1 2023 in Review

Santori & Peters Inc sold out of Bristol-Myers Squibb (BMY) in Q1 2023, closing a stake of 2,964 shares — an estimated $213K sold.

Santori & Peters Inc first reported a position in BMY in Q4 2017 and held it in 16 quarters. The position peaked at $791K in Q4 2020. 2,541 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

Santori & Peters Inc reported no remaining Bristol-Myers Squibb position as of Q1 2023 after selling out during the quarter.
Santori & Peters Inc sold 2,964 Bristol-Myers Squibb shares in Q1 2023, an estimated $213K.
Santori & Peters Inc first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 16 quarters.
Santori & Peters Inc's Bristol-Myers Squibb position peaked at $791K in Q4 2020.
2,541 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on Santori & Peters Inc's 13F filing for Q1 2023, filed 19 Apr 2023.